Marked for death: targeting epigenetic changes in cancer.

Abstract excerpt

In the past few years, it has become clear that mutations in epigenetic regulatory genes are common in human cancers. Therapeutic strategies are now being developed to target cancers with mutations in these genes using specific chemical inhibitors. In addition, a complementary approach based on the concept of synthetic lethality, which allows exploitation of loss-of-function mutations in cancers that are not...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Discovery
• Share to Enzyme Inhibitors
• Share to Epigenesis, Genetic